Physician

Michelle Carroll Bowman, M.D.

According to 2025 Medicare claims, Michelle Bowman, M.D. (NPI: 1699094532) practices neurology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Hamilton, OH. This provider's primary affiliated billing organization is RIVERHILLS HEALTHCARE INC (NPI: 1205943651; TIN: 311412447) and primary practice location at 45212-2280. Bowman is affiliated with the Healthcare Solutions Network (ACO ID: A3283), participating under the MSSP model.

Bowman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 194 traditional Medicare patients, billed 38,686 HCPCS/CPT codes, and received $1,379,564 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,238 prescription claims across 259 beneficiaries totaling $2,549,234 in drug costs, led by Kesimpta Pen (Ofatumumab). 2020 DME data shows 12 claims. Open Payments data shows 134 records totaling $48,468. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $4,735 to $1,379,564. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $617,948 to $2,549,234. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	33	45	$4,735
2016	132	227	$16,518
2017	104	182	$12,099
2018	116	511	$18,407
2019	183	32,190	$766,714
2020	182	30,248	$1,063,019
2021	191	30,296	$930,101
2022	190	34,702	$1,168,622
2023	208	32,092	$966,407
2024	194	38,686	$1,379,564

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	73	408	$617,948
2016	91	579	$744,689
2017	124	954	$1,161,417
2018	133	1,311	$1,336,303
2019	146	939	$1,480,250
2020	173	1,668	$3,022,233
2021	213	2,037	$3,910,484
2022	239	2,142	$3,307,343
2023	258	2,113	$2,781,022
2024	259	2,238	$2,549,234

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	12	$447
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	12	$83
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	57	76	$122
96413	Administration of chemotherapy into vein, 1 hour or less	25	31	$86
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	79	101	$79
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	38	128	$44
96375	Injection of additional new drug or substance into vein	25	64	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Kesimpta Pen	Ofatumumab	56	1,656	$500,698
Avonex Pen (4 Pack)	Interferon Beta-1a	37	1,260	$359,061
Mayzent	Siponimod	18	695	$220,073
Avonex (4 Pack)	Interferon Beta-1a	26	728	$209,853
Gammaplex	Immun Glob G(Igg)/Gly/Iga 0-50	30	630	$200,256

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$1,355	TG Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	121	$47,112	Roche Products Limited
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michelle Carroll Bowman, M.D.?

Tedicare shows public-source Medicare data for Michelle Carroll Bowman, M.D. (NPI 1699094532), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michelle Carroll Bowman, M.D. have ACO affiliation data?

Michelle Carroll Bowman, M.D. is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283).

What billing organization is linked to Michelle Carroll Bowman, M.D.?

Michelle Carroll Bowman, M.D. is linked to RIVERHILLS HEALTHCARE INC (billing NPI 1205943651) in the available physician profile data.

Does Michelle Carroll Bowman, M.D. have Open Payments data?

Michelle Carroll Bowman, M.D. has 134 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.